| Daptomycin M Heidary, AD Khosravi, S Khoshnood, MJ Nasiri, S Soleimani, ... Journal of Antimicrobial Chemotherapy 73 (1), 1-11, 2018 | 255 | 2018 |
| The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic A Shariati, M Arshadi, MA Khosrojerdi, M Abedinzadeh, M Ganjalishahi, ... Frontiers in public health 10, 1025633, 2022 | 163 | 2022 |
| A review on mechanism of action, resistance, synergism, and clinical implications of mupirocin against Staphylococcus aureus S Khoshnood, M Heidary, A Asadi, S Soleimani, M Motahar, M Savari, ... Biomedicine & Pharmacotherapy 109, 1809-1818, 2019 | 148 | 2019 |
| A comprehensive review of the protein subunit vaccines against COVID-19 M Heidary, VH Kaviar, M Shirani, R Ghanavati, M Motahar, M Sholeh, ... Frontiers in microbiology 13, 927306, 2022 | 147 | 2022 |
| Obesity and gut–microbiota–brain axis: A narrative review A Asadi, N Shadab Mehr, MH Mohamadi, F Shokri, M Heidary, ... Journal of clinical laboratory analysis 36 (5), e24420, 2022 | 110 | 2022 |
| Drug-resistant gram-negative uropathogens: A review S Khoshnood, M Heidary, R Mirnejad, A Bahramian, M Sedighi, H Mirzaei Biomedicine & Pharmacotherapy 94, 982-994, 2017 | 97 | 2017 |
| Bedaquiline: Current status and future perspectives S Khoshnood, M Goudarzi, E Taki, A Darbandi, E Kouhsari, M Heidary, ... Journal of global antimicrobial resistance 25, 48-59, 2021 | 84 | 2021 |
| Clofazimine: A useful antibiotic for drug-resistant tuberculosis R Mirnejad, A Asadi, S Khoshnood, H Mirzaei, M Heidary, L Fattorini, ... Biomedicine & Pharmacotherapy 105, 1353-1359, 2018 | 78 | 2018 |
| Mechanism of action, resistance, synergism, and clinical implications of azithromycin M Heidary, A Ebrahimi Samangani, A Kargari, A Kiani Nejad, I Yashmi, ... Journal of clinical laboratory analysis 36 (6), e24427, 2022 | 77 | 2022 |
| An overview on inactivated and live‐attenuated SARS‐CoV‐2 vaccines S Khoshnood, M Arshadi, S Akrami, M Koupaei, H Ghahramanpour, ... Journal of Clinical Laboratory Analysis 36 (5), e24418, 2022 | 70 | 2022 |
| Novel vaccine candidates against Mycobacterium tuberculosis S Khoshnood, M Heidary, M Haeili, M Drancourt, D Darban-Sarokhalil, ... International journal of biological macromolecules 120, 180-188, 2018 | 53 | 2018 |
| Mechanism of Action, Resistance, Synergism, and Clinical Implications of Delamanid Against Multidrug-Resistant Mycobacterium tuberculosis S Khoshnood, E Taki, N Sadeghifard, VH Kaviar, MH Haddadi, ... Frontiers in microbiology 12, 717045, 2021 | 50 | 2021 |
| Clinical characteristics, diagnosis, treatment, and mortality rate of TB/COVID-19 coinfectetd patients: a systematic review M Koupaei, A Naimi, N Moafi, P Mohammadi, FS Tabatabaei, ... Frontiers in medicine 8, 740593, 2021 | 49 | 2021 |
| Prevalence, diagnosis, and manifestations of brucellosis: A systematic review and meta-analysis S Khoshnood, R Pakzad, M Koupaei, M Shirani, A Araghi, GM Irani, ... Frontiers in Veterinary Science 9, 976215, 2022 | 47 | 2022 |
| Survey on Genetic Diversity, Biofilm Formation, and Detection of Colistin Resistance Genes in Clinical Isolates of Acinetobacter baumannii S Khoshnood, M Savari, E Abbasi Montazeri, A Farajzadeh Sheikh Infection and drug resistance, 1547-1558, 2020 | 46 | 2020 |
| The global prevalence of gastric cancer in Helicobacter pylori-infected individuals: a systematic review and meta-analysis M Shirani, R Pakzad, MH Haddadi, S Akrami, A Asadi, H Kazemian, ... BMC Infectious Diseases 23 (1), 543, 2023 | 42 | 2023 |
| Prevalence and antimicrobial resistance of Shigella species isolated from diarrheal patients in Ahvaz, southwest Iran AF Sheikh, M Moosavian, M Abdi, M Heidary, F Shahi, N Jomehzadeh, ... Infection and drug resistance, 249-253, 2019 | 42 | 2019 |
| Neurological manifestations in patients with COVID‐19: A systematic review and meta‐analysis M Mahdizade Ari, MH Mohamadi, N Shadab Mehr, S Abbasimoghaddam, ... Journal of Clinical Laboratory Analysis 36 (5), e24403, 2022 | 37 | 2022 |
| Molecular characterization of the pilS2 gene and its association with the frequency of Pseudomonas aeruginosa plasmid pKLC102 and PAPI-1 pathogenicity island A Bahramian, S Khoshnood, A Shariati, F Doustdar, AS Chirani, ... Infection and Drug Resistance, 221-227, 2019 | 34 | 2019 |
| Clinical manifestations, treatment options, and comorbidities in COVID‐19 relapse patients: A systematic review M Koupaei, MH Mohamadi, I Yashmi, AH Shahabi, AH Shabani, ... Journal of clinical laboratory analysis 36 (5), e24402, 2022 | 33 | 2022 |
Morteza SakiPh.D in Medical Bacteriology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranEmail verificata su ajums.ac.ir
